全球泌尿系统医疗设备市场规模、份额、趋势和成长分析报告（2026-2034年）

预计泌尿系统医疗设备市场将从 2025 年的 435.1 亿美元成长到 2034 年的 843.4 亿美元，2026 年至 2034 年的复合年增长率为 7.63%。

全球泌尿系统医疗设备市场持续稳定成长，反映出良性前列腺增生、肾结石、尿失禁和膀胱癌等泌尿系统疾病的发生率不断上升。器械类别包括内视镜、体外碎石系统、导尿管、支架和机器人辅助手术器械。由于微创手术的普及、诊断影像技术的进步以及筛检率的提高，医院、门诊手术中心和诊所对先进泌尿系统器械的需求日益增长。

市场的主要驱动因素包括人口老化、前列腺和膀胱疾病发病率上升，以及雷射碎石术、一次性柔软性输尿管镜和可降低感染风险的先进导管材料等技术创新。门诊和日间手术模式的激增正在推动对携带式一次性医疗器材的需求。微创治疗报销体系的完善和早期诊断意识提升进一步促进了市场扩张，而监管机构对一次性医疗器材安全性的关注正在影响产品的设计和应用。

展望未来，创新预计将聚焦于机器人技术、影像引导疗法和一次性医疗器械，以改善治疗效果并降低感染风险。精准医疗方法，例如靶向膀胱内治疗以及器械与药物的联合应用，或将涌现。新兴市场的扩张和泌尿系统医疗服务可近性的提高也将促进市场逐步成长。能够证明其产品具有临床价值、成本效益和感染控制优势的製造商，预计在未来十年内将占据更稳固的市场地位。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球泌尿系统医疗设备市场：依产品类型划分

• 市场分析、洞察与预测
• 内视镜
• 雷射和破碎设备
• 透析机
• 其他设备
• 配件

第五章 全球泌尿系统医疗设备市场：依应用领域划分

• 市场分析、洞察与预测
• 尿道结石
• 尿道恶性肿瘤
• 膀胱疾病
• 肾臟疾病
• 其他的

第六章 全球泌尿系统医疗设备市场：依最终用户划分

• 市场分析、洞察与预测
• 医院及门诊手术中心
• 透析中心
• 其他的

第七章 全球泌尿系统医疗设备市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Boston Scientific Corporation
  • Coloplast A/S
  • Ethicon Inc（Johnson & Johnson）
  • Ambu A/S
  • Karl Storz SE & Co. KG
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthcare GmbH
  • Stryker Corporation
  • Cook Medical Inc
  • Dornier Medtech GmbH
  • Rocamed SA

The Urology Devices Market size is expected to reach USD 84.34 Billion in 2034 from USD 43.51 Billion (2025) growing at a CAGR of 7.63% during 2026-2034.

The global urology devices market has grown steadily, reflecting rising prevalence of urological disorders such as benign prostatic hyperplasia, kidney stones, urinary incontinence, and bladder cancer. Device categories include endoscopes, lithotripsy systems, catheters, stents, and robotic-assisted surgical tools. Minimally invasive procedures, improved diagnostic imaging, and greater screening rates have driven demand for advanced urology devices across hospitals, ambulatory surgery centers, and outpatient clinics.

Drivers include aging populations, higher incidence of prostate and bladder conditions, and technological innovations like laser lithotripsy, single-use flexible ureteroscopes, and advanced catheter materials that reduce infection risk. A surge in outpatient and day-surgery models favors portable and disposable devices. Reimbursement improvements for minimally invasive interventions and growing awareness around early diagnosis further support market expansion, while regulatory focus on single-use device safety influences product design and adoption.

Looking ahead, innovation will concentrate on robotics, image-guided therapies, and device disposability to enhance outcomes and reduce infection. Precision medicine approaches, including targeted intravesical therapies and device-drug combinations, may emerge. Expansion in emerging markets and greater access to urological care will contribute incremental growth. Manufacturers that can demonstrate clinical value, cost-effectiveness, and infection-control benefits will secure stronger market positions over the next decade.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Endoscopes
• Laser & Lithotripsy Devices
• Dialysis Devices
• Other Devices
• Accessories

By Application

• Urolithiasis
• Urethral Malignancies
• Bladder Disorders
• Kidney Diseases
• Others

By End-user

• Hospitals & Ambulatory Surgical Centers
• Dialysis Centers
• Others

COMPANIES PROFILED

• Boston Scientific Corporation, Coloplast AS, Ethicon Inc Johnson Johnson, Ambu AS, Karl Storz SE Co KG, Olympus Corporation, Richard Wolf GmbH, Siemens Healthcare GmbH, Stryker Corporation, Cook Medical Inc, Dornier Medtech GmbH, Rocamed SA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL UROLOGY DEVICES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Endoscopes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Laser & Lithotripsy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Dialysis Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL UROLOGY DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Urolithiasis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Urethral Malignancies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Bladder Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Kidney Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL UROLOGY DEVICES MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals & Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Dialysis Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL UROLOGY DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL UROLOGY DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Boston Scientific Corporation
  • 9.2.2 Coloplast A/S
  • 9.2.3 Ethicon Inc (Johnson & Johnson)
  • 9.2.4 Ambu A/S
  • 9.2.5 Karl Storz SE & Co. KG
  • 9.2.6 Olympus Corporation
  • 9.2.7 Richard Wolf GmbH
  • 9.2.8 Siemens Healthcare GmbH
  • 9.2.9 Stryker Corporation
  • 9.2.10 Cook Medical Inc
  • 9.2.11 Dornier Medtech GmbH
  • 9.2.12 Rocamed SA